1. Loss of HER2 amplification and disease prognosis after neoadjuvant treatment of HER2 amplified breast cancer. (April 2018) Authors: Paralta Branco, F.; Silva, F.; André, S.; Catarino, A.; Madureira, R.; Moreira Pinto, J.; Godinho, J.; Simões, P.; Freitas, A.C.; Casa-Nova, M.; Nave, M.; Augusto, J.; Passos-Coelho, J.L. Journal: European journal of cancer Issue: Volume 92(2018)Supplement 3 Page Start: S94 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗